MADISON, Wisconsin – Fittingly enough given the locale of last week's MidAmerica Healthcare Venture Forum, the East and West Coast-based members of a panel on "Coast-to-Coast Healthcare Venture Capital Investing" showed an interest in steering some of their investment dollars to Midwestern start-ups. (Medical Device Daily)
MADISON, Wisconsin — With the initial public offering (IPO) window essentially nailed shut, the exit route for venture-backed healthcare companies is as clear as if it were marked in yellow highlighter: strategic investments and acquisitions by the sector's larger players. (Medical Device Daily)
Charles Craig, president of Georgia Bio (Atlanta), has been involved with the life sciences industry for 10 years, most recently as author and editor of Ernst & Young's Global Biotechnology Reports. He was responsible for production of publications tracking the progress of the life sciences industry in the Americas, Europe and Asia-Pacific. He introduced Ernst & Young's first Global Biotechnology Report in 2002 and its first Asia-Pacific Biotechnology Report in 2004. Craig also was a member of Ernst & Young's Global Health Sciences Center for Industry Change, assisting clients in strategic planning. (Biomedical Business & Technology)
Pamela McNamara is president of the U.S. business of Cambridge Consultants (Cambridge, UK/Cambridge, Massachusetts). She joined the company earlier this year and is leading its work in high-technology product and systems development for clients in the med-tech, wireless, defense and clean-tech sectors.
